Translate
Text Highlighter

Bookmark

PDF

Share

Report a problem
AMICUS AI
Citation Codes
Equivalent Citations
citation codes
Judges
Are you a practicing lawyer?
Enhance your digital presence and reach by creating a Casemine profile.
Upload pleading to use the new AI search
Cites
Cited by
Citation Codes
Equivalent Citations
citation codes
Judges

Sanofi Aventis Ireland Ltd. t/a Sanofi Pasteur v. Health Service Executive & anor

Smart Summary

Factual and Procedural Background

The judgment concerns an application for costs made by the notice party ("Defendant B") following judicial review proceedings initiated by the Applicant ("Plaintiff") challenging the award of a public contract by the Respondent ("Company A"). Defendant B was the successful tenderer for a five-year contract to supply a vaccine commencing January 2018. Plaintiff, as a disappointed tenderer, contested the award on grounds including adequacy of reasons, equality of treatment and transparency, and manifest error in the scoring of tenders. The court previously rejected Plaintiff's challenge except for a limited finding of inadequate reasons, which was deemed insufficient to set aside the contract award. Costs between Plaintiff and Company A were partly awarded. Defendant B, not fully involved in the substantive challenge, now seeks full recovery of its costs related to its participation as a notice party.

Legal Issues Presented

  1. Whether Defendant B, as a notice party joined to the judicial review proceedings, is entitled to recover its full party and party costs from Plaintiff.
  2. The extent to which a notice party's participation and contribution to the proceedings justify an award of costs.
  3. The application of principles governing costs awards to notice parties in judicial review, including considerations of necessity, reasonableness, and proportionality.

Arguments of the Parties

Defendant B's Arguments

  • As the successful tenderer, Defendant B had a direct and significant commercial interest in the outcome of the proceedings.
  • Defendant B's vaccine was challenged on safety and efficacy grounds, which justified its participation to protect its reputation.
  • There was a substantial need to preserve the confidentiality of Defendant B's commercially sensitive information, requiring active involvement.
  • Defendant B’s extensive experience as a tenderer positioned it to assist the court regarding the interpretation of tender documents.
  • Defendant B incurred costs related to a redaction protocol, a four-day hearing, and review of an overnight transcript, all of which it seeks to recover.

Plaintiff's Arguments

  • Confidentiality concerns could have been addressed through correspondence without full participation in proceedings.
  • The Respondent (Company A) had already extensively addressed the issues Defendant B raised, including those concerning another tenderer.
  • Plaintiff did not challenge the safety of Defendant B's vaccine but only argued that its own vaccine was superior, contesting the scoring on manifest error grounds.
  • Defendant B overstated its role and contribution, as the court’s judgment made no substantive reference to Defendant B’s submissions or evidence.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
Vodafone Ireland Limited v Commission for Communications Regulation [2015] IEHC 443 Established that notice parties who apply to be joined and defend their commercial interests may be entitled to costs; test involves considering the notice party’s interest and reasonableness of opposition. The court relied on this case to frame the test for awarding costs to notice parties, emphasizing the need to consider the extent and reasonableness of participation.
Usk & District Residents Association v EPA [2007] IEHC 30 Set out the test for costs entitlement of notice parties based on their interest and reasonableness of opposition. Referenced as part of the legal framework to assess whether Defendant B’s participation justified a costs award.
Treasury Holdings v NAMA [2012] IEHC 518 Affirmed the approach of considering the necessity and reasonableness of a notice party’s independent opposition when deciding costs. Used to support the principle that costs depend on the notice party’s role and contribution.
Telefonica O2 v Commission for Communications Regulation [2011] IEHC 380 Clarified that a right to be heard does not automatically entitle a notice party to full costs, especially if their contribution is marginal or duplicative. The court applied this principle to conclude that Defendant B’s full costs were not justified given the comprehensive defence by Company A and limited additional contribution.
Doyle v The Private Residential Tenancies Board [2016] IEHC 36 Held that costs for notice parties depend on degree and justification of participation; full costs are not automatic. Supported the court’s assessment that Defendant B’s full participation costs were disproportionate and only partial costs should be awarded.

Court's Reasoning and Analysis

The court began by acknowledging Defendant B’s significant commercial interest and legitimate concerns regarding the challenge to its vaccine and the protection of confidential information. It recognized that Defendant B was entitled to be heard and to take necessary steps to defend its interests, including filing affidavits and negotiating confidentiality protocols.

However, the court distinguished between the right to be heard and entitlement to full costs. It noted that the Respondent (Company A) mounted a comprehensive and robust defence that fully addressed the issues raised by Plaintiff, including those touching on Defendant B’s vaccine. Defendant B’s evidence and submissions did not materially add to the Respondent’s case, as reflected by the absence of references to Defendant B’s contributions in the substantive judgment.

Applying established case law, the court emphasized that costs awards to notice parties require a fact-specific assessment of whether full participation was reasonable and necessary. The court found that while Defendant B reasonably incurred costs related to joinder, affidavit evidence, confidentiality, and transcript review, it was not reasonable to expect Plaintiff to indemnify Defendant B for all costs associated with full participation, particularly when the Respondent had already provided a full defence.

The court referred to authoritative guidance stressing that notice parties should consider whether their involvement justifies full representation and that factual contributions might be made through affidavits rather than full litigation participation. This approach promotes proportionality and avoids unnecessary duplication of costs.

Holding and Implications

The court GRANTED IN PART and REFUSED IN PART Defendant B’s application for costs. Specifically, Defendant B was awarded party and party costs against Plaintiff only for:

  • Costs of the application to be joined as a notice party;
  • Costs of preparing and filing affidavit evidence;
  • Costs related to addressing confidentiality issues, including negotiating a redaction protocol;
  • Costs of the overnight transcript and its review by solicitor and counsel.

All other costs sought by Defendant B were refused. The court emphasized that this decision does not reflect adversely on Defendant B’s submissions but rather applies established principles to ensure costs are reasonable and proportionate.

The ruling underscores that notice parties have a right to be heard but are not automatically entitled to full costs of participation, especially where the principal respondent fully defends the case. The decision encourages parties to resolve costs disputes amicably and avoid disproportionate litigation over costs.

To access the original judgment, please Sign In or Subscribe.

Sanofi Aventis Ireland Ltd. t/a Sanofi Pasteur v Health Service Executive & anor

Contains public sector information licensed under the Open Justice Licence v1.0.

Use AI to get other relevant cases.

Comments

Sanofi Aventis Ireland Ltd. t/a Sanofi Pasteur v Health Service Executive & anor
(Dec 17, 2018)